Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

5.77
-0.0700-1.20%
Pre-market: 5.66-0.1104-1.91%08:28 EDT
Volume:936.49K
Turnover:5.41M
Market Cap:312.64M
PE:-1.60
High:6.06
Open:5.81
Low:5.61
Close:5.84
Loading ...

Emergent Biosolutions Price Target Maintained With a $16.00/Share by Rodman & Renshaw

Dow Jones
·
13 Sep 2024

BRIEF-Emergent Biosolutions Announces Agreement To Settle Securities Class Action Litigation

Reuters
·
13 Sep 2024

Emergent Biosolutions Signs $40 Million Settlement Deal to Resolve 2021 Class Action

MT Newswires Live
·
13 Sep 2024

Emergent Biosolutions Signs $40 Million Settlement Deal to Resolve 2021 Class Action

MT Newswires Live
·
13 Sep 2024

Emergent BioSolutions to Pay $40M to Settle Securities Class Action Suit

Dow Jones
·
13 Sep 2024

Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

THOMSON REUTERS
·
13 Sep 2024

Emergent BioSolutions Inc: Will Pay $40 Mln

THOMSON REUTERS
·
13 Sep 2024

Emergent BioSolutions Announces Agreement to Settle Securities Class Action Litigation

GlobeNewswire
·
13 Sep 2024

Emergent Biosolutions Awarded $41.9 Million Research, Development Option for Ebola Treatment

MT Newswires Live
·
12 Sep 2024

Emergent Biosolutions Awarded $41.9 Million Research, Development Option for Ebola Treatment

MT Newswires Live
·
12 Sep 2024

Emergent BioSolutions Awarded Research and Development Option Valued at $41.9 Million for Continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

THOMSON REUTERS
·
12 Sep 2024

Emergent BioSolutions Awarded Research and Development Option valued at $41.9 Million for continued Advanced Development and Procurement of Ebanga™ Treatment for Ebola

GlobeNewswire
·
12 Sep 2024

UPDATE 1-Rich nations have millions of mpox shots as Africa's outbreak spreads; Will they share?

Reuters
·
12 Sep 2024

BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc.

GuruFocus.com
·
12 Sep 2024